CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,36 · Q3 • database Scopus / SJR & Web of Science indexed
Hematology, Transfusion and Cell Therapy
Brazil · Elsevier Editora Ltda
workspace_premium Q3 — Immunology and Allergy visibility_off Double blind peer review lock_open Open Access

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a journal indexed in SJR in Immunology and Allergy and Hematology with an H index of 33. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on case reports, hematology, transfusion, hemotherapy. It has an SJR impact factor of 0,36 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,36.

ISSN: 2531-1379
Publisher: Elsevier Editora Ltda
Category: Immunology and Allergy
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,36 Q3
H-index 33
Acceptance rate pie_chart
38%
Source Acceptance_Rate
Time to publication hourglass_top
30 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
NPD Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,36

H-index

33

Docs (year)

239

Docs 3y

334

Total refs

5610

Cites 3y

422

Citable 3y

309

Cites/Doc 2y

1.24

Ref/Doc

23.47

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Hematology, Transfusion and Cell Therapy?

Hematology, Transfusion and Cell Therapy has an SJR of 0,36 (best quartile Q3) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is not available (NPD).

What is the acceptance rate?

The acceptance rate recorded for Hematology, Transfusion and Cell Therapy is 38%.